Oculus Innovative Sciences (OCLS)
Oculus Innovative Sciences Market Cap: 22.06M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
OCLS Market Cap Rankings
| Overall | 6th percentile | 4341 of 4663 |
| Sector | 9th percentile | 474 of 525 in Healthcare |
| Industry | 8th percentile | 62 of 68 in Medical Instruments & Supplies |
OCLS Market Cap Range, Past 5 Years
| Minimum | 22.06M | May 30 2012 |
| Maximum | 98.70M | Sep 2007 |
| Average | 48.95M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these OCLS related companies
OCLS News
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2012 Financial Results and Conference Call
May 24, 8:08AM GlobeNewswire
May 24, 8:08AM GlobeNewswire
$OCLS I have been watching this one and believe the bottom has been hit. Bought a chunk at .85 for a 3-6 month hold.
about 17 days ago by Chaput87
about 17 days ago by Chaput87
Oculus Innovative Sciences' Microcyn Acute Care Products Showcased at Symposium on Advanced Wound Care in Atlanta
Apr 26, 8:08AM GlobeNewswire
Apr 26, 8:08AM GlobeNewswire
Oculus Innovative Sciences to Raise $3.1 Million in Registered Direct Offering
Apr 23, 9:31AM Benzinga
Apr 23, 9:31AM Benzinga
Oculus Innovative Sciences, Inc. to Raise $3.1 Million in Registered Direct Offering
Apr 23, 9:30AM GlobeNewswire
Apr 23, 9:30AM GlobeNewswire
$OCLS is about to go much higher! I predict today close around 1.22$. Enjoy the ride :) http://stks.co/3KBX
about 49 days ago by ikabro
about 49 days ago by ikabro
$OCLS CEO Speaks Up on video interview with M.E. Garza - http://stks.co/34L4
about 66 days ago by ikabro
about 66 days ago by ikabro
Oculus (OCLS) Issues Several Key Updates; Reports Trailing 12-Month Revs of $12.1M
Mar 23, 8:13AM Street Insider
Mar 23, 8:13AM Street Insider
Oculus Innovative Sciences Provides Business Update From Roth Capital 23rd Annual Growth Conference
Mar 23, 8:08AM GlobeNewswire
Mar 23, 8:08AM GlobeNewswire
$OCLS new short interest numbers updated! lowest of all times - 2/29/2012 323,669 shares short! http://stks.co/2qSP
about 78 days ago by ikabro
about 78 days ago by ikabro
$ocls here comes the afternoon runup.. can it break the 200 dma. alot of positives news lately about this small company..
about 85 days ago by scottgrant2
about 85 days ago by scottgrant2
$ocls new bacteria cleaning products launched to us hospitals .. Boom Boom time !!! http://stks.co/2gjK
about 86 days ago by scottgrant2
about 86 days ago by scottgrant2
$OCLS just reclaimed nasdaq listing qualifications today, revenues could double next qtr, bull flag about to pushup to 1.60-1.70 range :)
about 89 days ago by scottgrant2
about 89 days ago by scottgrant2
$ocls it is trying hard to break thru 200mda, expect positive news on monday
about 90 days ago by scottgrant2
about 90 days ago by scottgrant2
Share an idea on $OCLS perfected bull flag just waiting to break thru 200 mda
about 91 days ago by scottgrant2
about 91 days ago by scottgrant2
$OCLS if economy recovering this stock will boom boom. revenues increased from 2 million to 10 million last 4 years in bad economy
about 91 days ago by scottgrant2
about 91 days ago by scottgrant2
Oculus Innovative Sciences Partner, Quinnova Pharmaceuticals, Launches Microcyn(R)-Based Atrapro(TM) Products
Feb 21, 8:08AM GlobeNewswire
Feb 21, 8:08AM GlobeNewswire
Oculus Innovative Sciences Reports Fiscal Third Quarter 2012 Financial Results
Feb 02, 4:05PM GlobeNewswire
Feb 02, 4:05PM GlobeNewswire
Oculus Innovative Sciences Announces Fiscal Third Quarter 2012 Financial Results and Conference Call
Jan 19, 8:08AM GlobeNewswire
Jan 19, 8:08AM GlobeNewswire
Oculus Innovative Sciences to Present at Biotech Showcase 2012 in San Francisco
Dec 29, 8:08AM GlobeNewswire
Dec 29, 8:08AM GlobeNewswire
Oculus Innovative Sciences Reports Record Fiscal Second Quarter 2012 Financial Results
Nov 03, 4:05PM GlobeNewswire
Nov 03, 4:05PM GlobeNewswire
Oculus Innovative Sciences files to sell 3.9M shares for selling stockholders
Oct 24, 7:43AM FlyOnTheWall
Oct 24, 7:43AM FlyOnTheWall
Oculus Innovative Sciences (OCLS) Files 3.89M Common Shelf for Selling Shareholders
Oct 24, 6:56AM Street Insider
Oct 24, 6:56AM Street Insider
Oculus Innovative Sciences Announces Fiscal Second Quarter 2012 Financial Results and Conference Call
Oct 21, 8:08AM GlobeNewswire
Oct 21, 8:08AM GlobeNewswire
Life Tech Capital Reiterates Strong Buy and PT of $4.75 on Oculus Innovative Sciences
Aug 12, 8:08AM Benzinga
Aug 12, 8:08AM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OCLS | 0.7309 | -0.03 | -3.83% | 22.06M |
| OCLRD | 2.51 | -0.13 | -4.92% | |
| OCLR | 2.51 | -0.13 | -4.92% | 135.85M |
| OCFC | 14.15 | -0.28 | -1.94% | 267.97M |
| OCC | 2.66 | -0.20 | -6.99% | 17.90M |
| OC | 30.72 | -1.21 | -3.79% | 3.879B |
| OBT | 4.50 | +0.20 | +4.65% | 13.03M |
| OBCI | 2.14 | +0.00 | +0.00% | 17.36M |
| OBAS | 1.21 | +0.00 | +0.00% | 23.06M |
| OB | 12.74 | -0.21 | -1.62% | 1.231B |